Activist Sherborne investor Edward Bramson steps up campaign against Barclays with plans to ask bank’s shareholders to elect him to its board and push for cut-back of its investment bank.
Disappointing annual results followed by sharp rebound spell good news for JPMorgan Indian ahead of investment trust's five-yearly continuation vote this month.
Baillie Gifford US Growth promotes deputy manager Helen Xiong to co-manager alongside Gary Robinson following earlier departure of Andrei Kiselev.
Robin Boyle, former managing director and fund manager of small-cap minnow Athelney, looks to regain control of board he quit three months ago and proposes moving trust to Gresham House.
James casts his analytical eye over some of the big winners and losers from 2018.
The merger & acquisition drive that has helped underpin impressive returns from listed biotechnology funds revives after Bristol-Myers Squibb mounts a record bid for cancer specialist Celgene.
Turmoil in US leveraged loans has hit Marble Point Loan Financing, one of last year's new investment company launches, pushing its net asset value down 8.5% in November.
Popularity of warehouse investing backfires on Aberdeen Standard European Logistics Income which is forced to trim its 5.5% dividend target one year after launch.
The sell-off of the last three months has bruised the global investment trust but its shares have done very well since Baillie Gifford's 'global alpha' team took it on in 2015.
Further evidence of China’s economic slowdown gets New Year off to poor start with both pound and UK stock market falling on first day of trading.